Cargando…

CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review

BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Ping, Wang, Qin, Qian, Qian, Wei, Shu-Zhen, Yu, Li-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212928/
https://www.ncbi.nlm.nih.gov/pubmed/22014025
http://dx.doi.org/10.1186/1756-9966-30-99
_version_ 1782216047745564672
author Zhan, Ping
Wang, Qin
Qian, Qian
Wei, Shu-Zhen
Yu, Li-Ke
author_facet Zhan, Ping
Wang, Qin
Qian, Qian
Wei, Shu-Zhen
Yu, Li-Ke
author_sort Zhan, Ping
collection PubMed
description BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubMed, Embase, Web of Science, and CNKI database was searched for case-control studies published up to June 2010. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: Ultimately, 64 studies, comprising 18,397 subjects from 49 case-control studies of the MspI genotype and 18,518 patients from 40 case-control studies of the exon 7 genotype, were included. A significantly elevated lung cancer risk was associated with 2 MspI genotype variants (for type C vs Type A: OR = 1.26, 95% CI = 1.12-1.42; for types B and C combined vs Type A: OR = 1.20, 95% CI = 1.13-1.28) in overall population. In the stratified analysis, a significant association was found in Asians, Caucasians, lung SCC, lung AC and Male population, not in mixed population, lung SCLC and Female population. However, inconsistent results were observed for CYP1A1 exon7 in our meta-analysis, two variants of the exon 7 polymorphism were associated with a significantly higher risk for lung cancer (for Val/Val vs Ile/Ile: OR = 1.24, 95% CI = 1.09-1.42; for (Ile/Val +Val/Val) vs Ile/Ile: OR = 1.15, 95% CI = 1.07-1.24) in overall population. In the stratified analysis, a significant assocation was found in Asians, Caucasians, lung SCC and Female population, not in mixed population, lung AD, lung SCLC and Male population. Additionally, a significant association was found in smoker population and not found in non-smoker populations for CYP1A1 MspI and exon7 gene. CONCLUSIONS: This meta-analysis suggests that the MspI and exon 7 polymorphisms of CYP1A1 correlate with increased lung cancer susceptibility and there is an interaction between two genotypes of CYP1A1 polymorphism and smoking, but these associations vary in different ethnic populations, histological types of lung caner and gender of case and control population.
format Online
Article
Text
id pubmed-3212928
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32129282011-11-11 CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review Zhan, Ping Wang, Qin Qian, Qian Wei, Shu-Zhen Yu, Li-Ke J Exp Clin Cancer Res Research BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubMed, Embase, Web of Science, and CNKI database was searched for case-control studies published up to June 2010. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: Ultimately, 64 studies, comprising 18,397 subjects from 49 case-control studies of the MspI genotype and 18,518 patients from 40 case-control studies of the exon 7 genotype, were included. A significantly elevated lung cancer risk was associated with 2 MspI genotype variants (for type C vs Type A: OR = 1.26, 95% CI = 1.12-1.42; for types B and C combined vs Type A: OR = 1.20, 95% CI = 1.13-1.28) in overall population. In the stratified analysis, a significant association was found in Asians, Caucasians, lung SCC, lung AC and Male population, not in mixed population, lung SCLC and Female population. However, inconsistent results were observed for CYP1A1 exon7 in our meta-analysis, two variants of the exon 7 polymorphism were associated with a significantly higher risk for lung cancer (for Val/Val vs Ile/Ile: OR = 1.24, 95% CI = 1.09-1.42; for (Ile/Val +Val/Val) vs Ile/Ile: OR = 1.15, 95% CI = 1.07-1.24) in overall population. In the stratified analysis, a significant assocation was found in Asians, Caucasians, lung SCC and Female population, not in mixed population, lung AD, lung SCLC and Male population. Additionally, a significant association was found in smoker population and not found in non-smoker populations for CYP1A1 MspI and exon7 gene. CONCLUSIONS: This meta-analysis suggests that the MspI and exon 7 polymorphisms of CYP1A1 correlate with increased lung cancer susceptibility and there is an interaction between two genotypes of CYP1A1 polymorphism and smoking, but these associations vary in different ethnic populations, histological types of lung caner and gender of case and control population. BioMed Central 2011-10-20 /pmc/articles/PMC3212928/ /pubmed/22014025 http://dx.doi.org/10.1186/1756-9966-30-99 Text en Copyright ©2011 Zhan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhan, Ping
Wang, Qin
Qian, Qian
Wei, Shu-Zhen
Yu, Li-Ke
CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title_full CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title_fullStr CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title_full_unstemmed CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title_short CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
title_sort cyp1a1 mspi and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212928/
https://www.ncbi.nlm.nih.gov/pubmed/22014025
http://dx.doi.org/10.1186/1756-9966-30-99
work_keys_str_mv AT zhanping cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview
AT wangqin cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview
AT qianqian cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview
AT weishuzhen cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview
AT yulike cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview